· Op-Ed/Commentary
COVID-19Intellectual Property Why Pay Less? The US Strategy for Vaccinating the WorldDean Baker / January 16, 2022
· Op-Ed/Commentary
COVID-19Intellectual Property Getting Ready for the Next Pandemic: Can We Get Patent Monopolies on the Table?Dean Baker / December 20, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryUnited States Inflation Fears Shouldn’t Be a Pretext for Class WarMax B. Sawicky / IN THESE TIMES / December 16, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and Recovery Could the Omicron Variant Be Good News?Dean Baker / December 11, 2021
· Op-Ed/Commentary
COVID-19 Washington Post Says School Employees Being Fired in LA Because of Vaccine Mandate are Less Than One Month’s Normal TurnoverDean Baker / December 11, 2021
· Op-Ed/Commentary
COVID-19 Yes Folks, Omicron Can be Blamed on Patent MonopoliesDean Baker / December 01, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryInequalityUnited StatesWomen Young Men Aren’t Falling Behind Young WomenShawn FremstadJulie Yixia CaiTamara Sokolowsky / October 13, 2021
· Op-Ed/Commentary
COVID-19Intellectual Property The Preventable Horrors of the Pandemic and the Short Case for Open ResearchDean Baker / October 11, 2021
· Op-Ed/Commentary
COVID-19Health and Social ProgramsInequalityUnited States Even During COVID-19 Recession, Temporary Assistance Does Little to Reduce Child PovertyAlgernon Austin / September 22, 2021
· Op-Ed/Commentary
COVID-19Intellectual PropertyTechnology Biden Can Transfer mRNA Technology and Leave the Legal Burdens with Moderna and PfizerDean Baker / September 22, 2021
